[Webinar] Model-informed Drug Repurposing - Applications for COVID-19

Examine the scientific basis for your COVID-19 study:
The global scientific community’s scramble to rapidly find therapeutics for COVID-19 has been reassuring, but unfortunately also chaotic. There are now almost 700 clinical trials conducted, planned or in progress – many with poor rationale for the drugs and dosing regimens being investigated. Now more than ever, the clinical and quantitative pharmacology community must use their state-of-the-art tools and expertise to efficiently identify the right drug at the right dose for the right patient to fight COVID-19.

This webinar was recorded on Thursday, May 14 2020.